Sunday, May 5, 2024     8:00 AM – 11:30 AM ET     Skyline Ballroom W375C

Major Symposium C

Unleashing Targets for Novel Cancer Immunotherapies: Beyond T Cell Checkpoints

Chairs
José R. Conejo-Garcia, Duke Univ. Sch. of Med., USA
Paulo C. Rodriguez, Moffitt Cancer Ctr., USA

Speakers
Tyler I. Curiel, Dartmouth Col., USA, Cell-intrinsic PD-L1 signals as actionable cancer immunotherapy targets
José R. Conejo-Garcia, Duke Univ. Sch. of Med., USA, Harnessing coordinated humoral and cellular responses in human cancer
Sana Mir, UR Med., USA, Universally conserved signals for CAR T cell migration to solid tumors
Dmitry Gabrilovich, AstraZeneca, Myeloid cells in cancer: old challenges and new opportunities
Yating Zheng, Univ. of Michigan Med. Sch., USA, An engineered viral protein rewires signaling pathways to overcome T cell suppression
Paulo C. Rodriguez, Moffitt Cancer Ctr., USA, Strategies to restore protective immunity in cancer hosts by targeting Notch signaling
Catherine J. Wu, Dana-Farber Cancer Inst., USA, Updates on personal cancer vaccines